“There's often a binary debate occurring in society, which is about crypto assets—is the asset class a zero? And it's a bit of the wrong debate to be having. The right question to ask here is, are there crypto-assets that deserve a weighting in your portfolio?” – Joe Percoco
Joe Percoco (@joepercoco) is Co-CEO and Co-Founder of Titan, an investment firm focused on leveling the playing field across the wealth spectrum. Titan manages over $500M for 30,000 clients and has recently been valued at $450 million at the close of their Series B round. Before launching Titan, Joe Percoco managed investments at Goldman Sachs and McKinsey & Company.
For more, explore the transcript of this episode.
Chapters in this interview:
- Joe’s background and insights learned at Goldman Sachs and McKinsey
- The frustrations in investing that led Joe to build Titan
- Investing in international markets
- Building a platform that makes investing accessible to all
- Investing in crypto with Titan
- Understanding your Company OS and hiring the right people for your tribe
Links from this episode
- Connect with Joe Percoco: Joe’s Twitter | Titan’s Twitter | LinkedIn | Titan
- The Wharton School
- Goldman Sachs
- David Solomon
- McKinsey & Company
- Morgan Stanley
- Jack Bogle
- Amsterdam Stock Exchange
- Dutch East India Company
- LeBron James
- Phil Jackson
- Warren Buffett
- Charlie Munger
- Philippe Laffont
- Coatue Management
- Voltaire quote: "Judge a man by his questions rather than his answers."
- Eric Wu
Book Recommended by Joe
- Thing Explainer: Complicated Stuff in Simple Words by Randall Munroe
Joe places a lot of weight on company culture and the importance of finding team members that really fit into the established tribe. He compares this to understanding your company’s operating system, it’s core “biology,” and assessing whether potential team members truly connect at that level.
“The second most important product you ship is how everyone works together. The biggest unlock is the realization that most people underweight working on the company OS. And if you think about a company, at a molecular level, the biology of a company, what is the atom? And is this a high-performing atom? Or is this a mediocre atom?”